Skip to main content

Peer Review reports

From: Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study

Original Submission
4 Jul 2022 Submitted Original manuscript
9 Jul 2022 Author responded Author comments - Hong-jian Li
Resubmission - Version 2
9 Jul 2022 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
15 Feb 2023 Reviewed Reviewer Report
1 Mar 2023 Reviewed Reviewer Report
12 Mar 2023 Author responded Author comments - Hong-jian Li
Resubmission - Version 4
12 Mar 2023 Submitted Manuscript version 4
11 Apr 2023 Reviewed Reviewer Report
15 Apr 2023 Reviewed Reviewer Report
18 Apr 2023 Author responded Author comments - Hong-jian Li
Resubmission - Version 5
18 Apr 2023 Submitted Manuscript version 5
19 Apr 2023 Author responded Author comments - Hong-jian Li
Resubmission - Version 6
19 Apr 2023 Submitted Manuscript version 6
Publishing
26 Apr 2023 Editorially accepted
20 May 2023 Article published 10.1186/s12887-023-04039-5

You can find further information about peer review here.

Back to article page